Kaifang Ma

989 total citations
28 papers, 614 citations indexed

About

Kaifang Ma is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kaifang Ma has authored 28 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kaifang Ma's work include Cancer, Hypoxia, and Metabolism (12 papers), Renal cell carcinoma treatment (6 papers) and RNA modifications and cancer (6 papers). Kaifang Ma is often cited by papers focused on Cancer, Hypoxia, and Metabolism (12 papers), Renal cell carcinoma treatment (6 papers) and RNA modifications and cancer (6 papers). Kaifang Ma collaborates with scholars based in China, Poland and Finland. Kaifang Ma's co-authors include Kan Gong, Jingcheng Zhou, Kenan Zhang, Haibiao Xie, Baoan Hong, Lin Cai, Yanqing Gong, Wuping Yang, Jiangyi Wang and Bowen Zhou and has published in prestigious journals such as Cell Death and Disease, Journal of Medical Genetics and Frontiers in Oncology.

In The Last Decade

Kaifang Ma

26 papers receiving 614 citations

Peers

Countries citing papers authored by Kaifang Ma

Since Specialization

Citations

This map shows the geographic impact of Kaifang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaifang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaifang Ma more than expected).

Fields of papers citing papers by Kaifang Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaifang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaifang Ma. The network helps show where Kaifang Ma may publish in the future.

Co-authorship network of co-authors of Kaifang Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Kaifang Ma. A scholar is included among the top collaborators of Kaifang Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaifang Ma. Kaifang Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Study on the intervention effect of HCH integrated SMG health management model on community high-risk group of cardiovascular disease 2024 ·Frontiers in Cardiovascular Medicine ·Rui Du, Kaifang Ma, (unknown), Jin Hui Tian, (unknown), (unknown), (unknown)	1
2	Preliminary Study of Whole-Genome Bisulfite Sequencing and Transcriptome Sequencing in VHL Disease-Associated ccRCC 2023 ·Molecular Diagnosis & Therapy ·(unknown), (unknown), Yawei Xu, Wuping Yang, Zedan Zhang, Kaifang Ma, Kenan Zhang, Jingcheng Zhou, Yanqing Gong, Weimin Ci, Kan Gong	1
3	A Novel Cuproptosis-Related Prognostic Model and the Hub Gene FDX1 Predict the Prognosis and Correlate with Immune Infiltration in Clear Cell Renal Cell Carcinoma 2022 ·Journal of Oncology ·Kenan Zhang, Wuping Yang, Zedan Zhang, Kaifang Ma, (unknown), Yawei Xu, (unknown), (unknown), Jingcheng Zhou, Lin Cai, Yanqing Gong, Kan Gong	4
4	Downregulation of FXYD2 Is Associated with Poor Prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma 2022 ·Journal of Immunology Research ·Zedan Zhang, (unknown), (unknown), Wuping Yang, Yawei Xu, Jingcheng Zhou, Kaifang Ma, Kenan Zhang, Hongkai Zhuang, Yanqing Gong, Kan Gong	8
5	Genotype–phenotype correlations and clinical outcomes of patients with von Hippel-Lindau disease with large deletions 2022 ·Journal of Medical Genetics ·Kenan Zhang, Wuping Yang, Kaifang Ma, (unknown), Lei Li, Yawei Xu, Zedan Zhang, (unknown), Jingcheng Zhou, Yanqing Gong, Lin Cai, Kan Gong	0
6	FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability 2022 ·International Journal of Biological Sciences ·Yawei Xu, Jingcheng Zhou, Lei Li, Wuping Yang, Zedan Zhang, Kenan Zhang, Kaifang Ma, Haibiao Xie, Zheng Zhang, (unknown), Yanqing Gong, Kan Gong	60
7	VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells 2022 ·Cell & Bioscience ·Xueyou Ma, (unknown), Qin Zhang, Kaifang Ma, Jun Xiao, Xiong Wang, Yanan Wang, (unknown), Yu Wang, Jing Li, Xing Zeng, Wei Guan, Shaogang Wang, Kan Gong, Gong‐Hong Wei, Zhihua Wang	5
8	Association between vasectomy and risk of prostate cancer: a meta-analysis 2021 ·Prostate Cancer and Prostatic Diseases ·Yawei Xu, Lei Li, Wuping Yang, Kenan Zhang, Kaifang Ma, Haibiao Xie, Jingcheng Zhou, Lin Cai, Yanqing Gong, Zheng Zhang, Kan Gong	4
9	Clinical characteristics and risk factors for survival in affected offspring of von Hippel-Lindau disease patients 2021 ·Journal of Medical Genetics ·Kenan Zhang, (unknown), Wuping Yang, Kaifang Ma, Lei Li, Haibiao Xie, Yawei Xu, Yanqing Gong, Jingcheng Zhou, Lin Cai, Kan Gong	5
10	Cell-cycle arrest and senescence in TP53-wild type renal carcinoma by enhancer RNA-P53-bound enhancer regions 2 (p53BER2) in a p53-dependent pathway 2021 ·Cell Death and Disease ·Haibiao Xie, Kaifang Ma, Kenan Zhang, Jingcheng Zhou, Lei Li, Wuping Yang, Yanqing Gong, Lin Cai, Kan Gong	123
11	Novel genetic characterisation and phenotype correlation in von Hippel-Lindau (VHL) disease based on the Elongin C binding site: a large retrospective study 2020 ·Journal of Medical Genetics ·Haibiao Xie, Kaifang Ma, (unknown), Baoan Hong, Jingcheng Zhou, Lei Li, Kenan Zhang, Kan Gong, Lin Cai	5
12	CLDN10 Associated with Immune Infiltration is a Novel Prognostic Biomarker for Clear Cell Renal Cell Carcinoma 2020 ·Epigenomics ·Wuping Yang, Lei Li, Kenan Zhang, Kaifang Ma, Yanqing Gong, Jingcheng Zhou, Kan Gong	15
13	The Genotype-Phenotype Association of Von Hipple Lindau Disease Based on Mutation Locations: A Retrospective Study of 577 Cases in a Chinese Population 2020 ·Frontiers in Genetics ·(unknown), Kenan Zhang, Kaifang Ma, Jingcheng Zhou, Yanqing Gong, Lin Cai, Kan Gong	6
14	Natural history of renal tumours in von Hippel-Lindau disease: a large retrospective study of Chinese patients 2019 ·Journal of Medical Genetics ·Xiang Peng, Jinchao Chen, (unknown), Shuanghe Peng, Shengjie Liu, Kaifang Ma, Jingcheng Zhou, Baoan Hong, Bowen Zhou, (unknown), Lin Cai, Kan Gong	10
15	The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel–Lindau Disease: A Retrospective Study of 32 Patients 2019 ·Frontiers in Oncology ·Kaifang Ma, Baoan Hong, Jingcheng Zhou, Yanqing Gong, Jiangyi Wang, Shengjie Liu, Xiang Peng, Bowen Zhou, (unknown), Haibiao Xie, Kenan Zhang, Lei Li, (unknown), Zixin Wang, Lin Cai, Kan Gong	10
16	Frequent Mutations of VHL Gene and the Clinical Phenotypes in the Largest Chinese Cohort With Von Hippel–Lindau Disease 2019 ·Frontiers in Genetics ·Baoan Hong, Kaifang Ma, Jingcheng Zhou, (unknown), Jiangyi Wang, Shengjie Liu, Zhongyuan Zhang, Lin Cai, Ning Zhang, Kan Gong	20
17	Intra-Familial Phenotypic Heterogeneity and Telomere Abnormality in von Hippel- Lindau Disease: Implications for Personalized Surveillance Plan and Pathogenesis of VHL-Associated Tumors 2019 ·Frontiers in Genetics ·Jiangyi Wang, Xiang Peng, Cen Chen, Xianghui Ning, Shuanghe Peng, Teng Li, Shengjie Liu, Baoan Hong, Jingcheng Zhou, Kaifang Ma, Lin Cai, Kan Gong	6
18	Hemangioblastoma Instead of Renal Cell Carcinoma Plays a Major Role in the Unfavorable Overall Survival of Von Hippel-Lindau Disease Patients 2019 ·Frontiers in Oncology ·Bowen Zhou, Jiangyi Wang, Shengjie Liu, Xiang Peng, Baoan Hong, Jingcheng Zhou, Kaifang Ma, (unknown), Lin Cai, Kan Gong	13
19	Differential Expression of PD-L1 Between Sporadic and VHL-Associated Hereditary Clear-Cell Renal Cell Carcinoma and Its Correlation With Clinicopathological Features 2018 ·Clinical Genitourinary Cancer ·Baoan Hong, Lin Cai, Jiangyi Wang, Shengjie Liu, Jingcheng Zhou, Kaifang Ma, (unknown), Bowen Zhou, Xiang Peng, Ning Zhang, Kan Gong	7
20	Genotype and phenotype correlation in von Hippel–Lindau disease based on alteration of the HIF-α binding site in VHL protein 2018 ·Genetics in Medicine ·Shengjie Liu, Jiangyi Wang, Shuanghe Peng, Teng Li, Xianghui Ning, Baoan Hong, Jiayuan Liu, Pengjie Wu, Bowen Zhou, Jingcheng Zhou, (unknown), Xiang Peng, (unknown), Kaifang Ma, Lin Cai, Kan Gong	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact